Dear Shareholders,
The global economic landscape has been significantly influenced by the
Covid-19 pandemic and recent geopolitical events, including the ongoing conflicts in
Eastern Europe, Middle East and our neighboring countries. These factors have heightened
global economic uncertainty. Inflation, exacerbated by supply chain disruptions, has
affected economies worldwide, and the central banks responses—through tight monetary
and fiscal policies—have further impacted consumer confidence. According to current
reports, advanced economies are expected to experience the most pronounced effects of this
slowdown, while emerging markets and developing economies may face a less severe impact.
I would like to mention that the presence of TRUPCR? assays has been
well-established in over 60 countries across the UK, Europe, the Middle East, APAC, LATAM,
and the United States. We have recently expanded into additional countries in Southeast
Asia and the Middle East through our channel partners. We are actively working to enhance
our global footprint by adding more channel partners in various regions. Despite the
increase in molecular diagnostic labs and manufacturers globally post-Covid, we remain
well-positioned to navigate the competitive landscape with our robust product range,
exemplary customer support, and highly regarded quality.
We are also in the process of registering our products in markets where
demand is strong, in accordance with local medical device regulations. This will
facilitate easier access and preference in these markets.
The Board of Directors has proposed a dividend of ^3/- per equity share
of ^10/- face value, pending shareholder approval at the forthcoming Annual General
Meeting.
As we review the past year, I would like to extend my sincere gratitude
to our supply and trade partners for their efforts in ensuring the timely availability of
our products.
With a clear strategy and a dedicated, skilled team supporting its
implementation, we are confident in our ability to sustain this growth trajectory, achieve
our future growth objectives, and deliver long-term value to our shareholders.
Finally, I wish to express my heartfelt thanks to all our employees,
customers, stakeholders, and associates, and wish them continued success in their
endeavors.
| JAI HIND |
| Dhirendra Dubey |
| Chairman & Managing Director |